Cargando…
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
The aim of the study was to investigate the effects of arsenic trioxide (As(2)O(3)) treatment on the expression of ezrin and serum alpha-fetoprotein (AFP) levels in hepatocellular carcinoma (HCC). A total of 24 patients (20 males and 4 females) with resectable HCC were treated with venous injection...
Autores principales: | Lu, Wei, Yang, Chao, Du, Peng, Zhang, Jun-Li, Zhang, Jia-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585476/ https://www.ncbi.nlm.nih.gov/pubmed/28858082 http://dx.doi.org/10.1097/MD.0000000000007602 |
Ejemplares similares
-
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
por: Kong, Degang, et al.
Publicado: (2020) -
The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017) -
Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019) -
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo
por: Song, Jingjing, et al.
Publicado: (2016) -
Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016)